We are honored to announce that Dr. Tse-Wen Chang, Chairman of T-E Pharma, and Dr. Hsin-Mao Chu, CEO of the T-E Pharma, have been invited to participate in BIOLOGICS WORLD TAIWAN 2026, to be held in Taiwan, where they will deliver keynote presentations.
 
  • Chairman Dr. Chang will speak on “Novel Pharmaceuticals with Targeting and Effector Moieties”, sharing the latest clinical results of Immunwork’s two clinical-stage drug candidates TE-8105 and TE-8214, as well as the design concepts and development progress of the TE-6168 drug for ischemic stroke.
  • CEO Dr. Chu will present on “Developing Efficacious, Stable, and Safe High-DAR Mono- and Dual-Payload ADCs via Modular Multi-Arm Drug Bundle Technology”, introducing the T-E Meds’ modular drug-bundle platform technology developed and the latest progress of multiple drug candidates.

BIOLOGICS WORLD TAIWAN is Taiwan’s premier annual biotherapeutics industry event, organized by the international biomedical conference organization IMAPAC. The forum focuses on industry trends, clinical development, manufacturing, and business strategies. We sincerely invite professionals from all sectors to attend, engage, and exchange insights.

BIOLOGICS WORLD TAIWAN 2026 website: https://info.imapac.com/brochure/bwt2026/
 

 
Back to the top